Pfizer to acquire obesity treatment start-up Metsera in $10 billion deal

The deal announcement marked the end of the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

Leave a Reply

Your email address will not be published. Required fields are marked *